Bronchitis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: B7473735AEE8EN
Market Monitor Global

Abstracts

Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue, shortness of breath, chest discomfort, production of mucus, etc.

This report contains market size and forecasts of Bronchitis Treatment in Global, including the following market information:

Global Bronchitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bronchitis Treatment market was valued at 3082.6 million in 2021 and is projected to reach US$ 3704.2 million by 2028, at a CAGR of 2.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bronchitis Treatment include AstraZeneca, Boehringer Ingelheim International, GlaxoSmithKline, Novartis AG, Melinta Therapeutics, Dr Reddy’s Laboratories and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bronchitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bronchitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bronchitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Anti-allergy Drugs (Antihistamines)
• Bronchodilators
• Mucolytics
• Others

Global Bronchitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bronchitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Bronchitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bronchitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bronchitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bronchitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Boehringer Ingelheim International
• GlaxoSmithKline
• Novartis AG
• Melinta Therapeutics
• Dr Reddy’s Laboratories
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bronchitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bronchitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRONCHITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Bronchitis Treatment Market Size: 2021 VS 2028
2.2 Global Bronchitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bronchitis Treatment Players in Global Market
3.2 Top Global Bronchitis Treatment Companies Ranked by Revenue
3.3 Global Bronchitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Bronchitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bronchitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bronchitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Bronchitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bronchitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bronchitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Anti-allergy Drugs (Antihistamines)
  4.1.4 Bronchodilators
  4.1.5 Mucolytics
  4.1.6 Others
4.2 By Type - Global Bronchitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Bronchitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Bronchitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Bronchitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bronchitis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Bronchitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Bronchitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Bronchitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Bronchitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bronchitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Bronchitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Bronchitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Bronchitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Bronchitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bronchitis Treatment Revenue, 2017-2028
  6.3.2 US Bronchitis Treatment Market Size, 2017-2028
  6.3.3 Canada Bronchitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Bronchitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bronchitis Treatment Revenue, 2017-2028
  6.4.2 Germany Bronchitis Treatment Market Size, 2017-2028
  6.4.3 France Bronchitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Bronchitis Treatment Market Size, 2017-2028
  6.4.5 Italy Bronchitis Treatment Market Size, 2017-2028
  6.4.6 Russia Bronchitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Bronchitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Bronchitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bronchitis Treatment Revenue, 2017-2028
  6.5.2 China Bronchitis Treatment Market Size, 2017-2028
  6.5.3 Japan Bronchitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Bronchitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Bronchitis Treatment Market Size, 2017-2028
  6.5.6 India Bronchitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bronchitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Bronchitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Bronchitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bronchitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Bronchitis Treatment Market Size, 2017-2028
  6.7.3 Israel Bronchitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Bronchitis Treatment Market Size, 2017-2028
  6.7.5 UAE Bronchitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Bronchitis Treatment Major Product Offerings
  7.1.4 AstraZeneca Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Boehringer Ingelheim International
  7.2.1 Boehringer Ingelheim International Corporate Summary
  7.2.2 Boehringer Ingelheim International Business Overview
  7.2.3 Boehringer Ingelheim International Bronchitis Treatment Major Product Offerings
  7.2.4 Boehringer Ingelheim International Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Boehringer Ingelheim International Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Bronchitis Treatment Major Product Offerings
  7.3.4 GlaxoSmithKline Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Bronchitis Treatment Major Product Offerings
  7.4.4 Novartis AG Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Melinta Therapeutics
  7.5.1 Melinta Therapeutics Corporate Summary
  7.5.2 Melinta Therapeutics Business Overview
  7.5.3 Melinta Therapeutics Bronchitis Treatment Major Product Offerings
  7.5.4 Melinta Therapeutics Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Melinta Therapeutics Key News
7.6 Dr Reddy’s Laboratories
  7.6.1 Dr Reddy’s Laboratories Corporate Summary
  7.6.2 Dr Reddy’s Laboratories Business Overview
  7.6.3 Dr Reddy’s Laboratories Bronchitis Treatment Major Product Offerings
  7.6.4 Dr Reddy’s Laboratories Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Dr Reddy’s Laboratories Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Bronchitis Treatment Major Product Offerings
  7.7.4 Sanofi Bronchitis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bronchitis Treatment Market Opportunities & Trends in Global Market
Table 2. Bronchitis Treatment Market Drivers in Global Market
Table 3. Bronchitis Treatment Market Restraints in Global Market
Table 4. Key Players of Bronchitis Treatment in Global Market
Table 5. Top Bronchitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bronchitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bronchitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bronchitis Treatment Product Type
Table 9. List of Global Tier 1 Bronchitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bronchitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bronchitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bronchitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bronchitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bronchitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bronchitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bronchitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bronchitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bronchitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bronchitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bronchitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bronchitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bronchitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bronchitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bronchitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bronchitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bronchitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bronchitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bronchitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bronchitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Bronchitis Treatment Product Offerings
Table 32. AstraZeneca Bronchitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim International Corporate Summary
Table 34. Boehringer Ingelheim International Bronchitis Treatment Product Offerings
Table 35. Boehringer Ingelheim International Bronchitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Bronchitis Treatment Product Offerings
Table 38. GlaxoSmithKline Bronchitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Bronchitis Treatment Product Offerings
Table 41. Novartis AG Bronchitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Melinta Therapeutics Corporate Summary
Table 43. Melinta Therapeutics Bronchitis Treatment Product Offerings
Table 44. Melinta Therapeutics Bronchitis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Dr Reddy’s Laboratories Corporate Summary
Table 46. Dr Reddy’s Laboratories Bronchitis Treatment Product Offerings
Table 47. Dr Reddy’s Laboratories Bronchitis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Bronchitis Treatment Product Offerings
Table 50. Sanofi Bronchitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bronchitis Treatment Segment by Type in 2021
Figure 2. Bronchitis Treatment Segment by Application in 2021
Figure 3. Global Bronchitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bronchitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bronchitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bronchitis Treatment Revenue in 2021
Figure 8. By Type - Global Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bronchitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bronchitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim International Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Melinta Therapeutics Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dr Reddy’s Laboratories Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Bronchitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)